Template:Tamoxifen_dosage_and_incidence_of_breast_symptoms_with_bicalutamide_in_men

Template:Tamoxifen dosage and incidence of breast symptoms with bicalutamide in men

More information Follow-up timepoint, Tamoxifen dosage ...

This article uses material from the Wikipedia article Template:Tamoxifen_dosage_and_incidence_of_breast_symptoms_with_bicalutamide_in_men, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.

Follow-up timepoint	Tamoxifen dosage
Follow-up timepoint	Placebo	1 mg/day	2.5 mg/day	5 mg/day	10 mg/day	20 mg/day
0 months	–
6 months	98%	90%	80%	54%	22%	10%
12 months	99%	95%	84%	56%	38%	19%
Notes: Prevention of breast symptoms—specifically gynecomastia and breast pain—induced by 150 mg/day bicalutamide monotherapy with tamoxifen in 282 men with prostate cancer. Bicalutamide and tamoxifen were initiated at the same time (0 months). Estradiol levels were in the range of about 22 to 47 pg/mL in the treated group.^[1] Sources: ^[2]^[1]

References